1
|
Reya T, Morrison SJ, Clarke SF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
2
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
3
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
et al: Prospective identification of tumorigenic breast cancer
cells. Proc Natl Acad Sci USA. 100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
4
|
Singh SK, Clarke ID, Terasaki M, et al:
Identification of a cancer stem cell in human brain tumors. Cancer
Res. 63:5821–5828. 2003.PubMed/NCBI
|
5
|
Patrawala L, Calhoun T,
Schneider-Broussard R, et al: Highly purified CD44+ prostate cancer
cells from xenograft human tumors are enriched in tumorigenic and
metastatic progenitor cells. Oncogene. 25:1696–1708. 2006.
|
6
|
Baba T, Convery PA, Matsumura N, et al:
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian
cancer cells. Oncogene. 28:209–218. 2009.
|
7
|
Zhang S, Balch C, Chan MW, et al:
Identification and characterization of ovarian cancer-initiating
cells from primary human tumors. Cancer Res. 68:4311–4320. 2008.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Goodell MA, Brose K, Paradis G, et al:
Isolation and functional properties of murine hematopoietic stem
cells that are replicating in vivo. J Exp Med. 183:1797–1806. 1996.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Hayashi S, Fujita K, Matsumoto S, et al:
Isolation and identification of cancer stem cells from a side
population of a human hepatoblastoma cell line, HuH-6 clone-5.
Pediatr Surg Int. 27:9–16. 2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Wang J, Guo LP, Chen LZ, et al:
Identification of cancer stem cell-like side population cells in
human nasopharyngeal carcinoma cell line. Cancer Res. 67:3716–3724.
2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Gao Q, Geng L, Kvalheim G, et al:
Identification of cancer stem-like side population cells in ovarian
cancer cell line OVCAR-3. Ultrastruct Pathol. 33:175–181. 2009.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Kondo T, Setoguchi T and Taga T:
Persistence of a small subpopulation of cancer stem-like cells in
the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Storms RW, Goodell MA, Fisher A, et al:
Hoechst dye efflux reveals a novel CD7(+)CD34(−) lymphoid
progenitor in human umbilical cord blood. Blood. 96:2125–2133.
2000.PubMed/NCBI
|
14
|
Iwatani H, Ito T, Imai E, et al:
Hematopoietic and nonhematopoietic potentials of Hoechst(low)/side
population cells isolated from adult rat kidney. Kidney Int.
65:1604–1614. 2004. View Article : Google Scholar : PubMed/NCBI
|
15
|
Clayton H, Titley I and Vivanco Md: Growth
and differentiation of progenitor/stem cells derived from the human
mammary gland. Exp Cell Res. 297:444–460. 2004. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Wang J, Guo LP, Chen LZ, et al:
Identification of cancer stem cell-like side population cells in
human nasopharyngeal carcinoma cell line. Cancer Res. 67:3716–3724.
2007. View Article : Google Scholar : PubMed/NCBI
|
18
|
Morrison SJ and Kimble J: Asymmetric and
symmetric stem-cell divisions in development and cancer. Nature.
441:1068–1074. 2006. View Article : Google Scholar : PubMed/NCBI
|
19
|
Clevers H: Stem cells, asymmetric division
and cancer. Nat Genet. 37:1027–1028. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Fürthauer M and González-Gaitan M:
Endocytosis, asymmetric cell division, stem cells and cancer: unus
pro omnibus, omnes pro uno. Mol Oncol. 3:339–353. 2009.PubMed/NCBI
|
21
|
Neumüller RA and Knoblich JA: Dividing
cellular asymmetry: asymmetric cell division and its implications
for stem cells and cancer. Genes Dev. 23:2675–2699. 2009.PubMed/NCBI
|
22
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar
|
23
|
Zhou S, Schuetz JD, Bunting KD, et al: The
ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem
cells and is a molecular determinant of the side-population
phenotype. Nat Med. 7:1028–1034. 2001. View Article : Google Scholar : PubMed/NCBI
|
24
|
Balabanov S, Gontarewicz A, Keller G, et
al: Abcg2 overexpression represents a novel mechanism for acquired
resistance to the multi-kinase inhibitor Danusertib in
BCR-ABL-positive cells in vitro. PLoS One. 6:e191642011. View Article : Google Scholar : PubMed/NCBI
|
25
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
et al: Identification and expansion of human
colon-cancer-initiating cells. Nature. 445:111–115. 2007.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Hermann PC, Huber SL, Herrler T, et al:
Distinct populations of cancer stem cells determine tumor growth
and metastatic activity in human pancreatic cancer. Cell Stem Cell.
1:313–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
27
|
Yang ZF, Ho DW, Ng MN, et al: Significance
of CD90+ cancer stem cells in human liver cancer. Cancer Cell.
13:153–166. 2008.
|
28
|
Zhou L, Wei X, Cheng L, et al: CD133, one
of the markers of cancer stem cells in Hep-2 cell line.
Laryngoscope. 117:455–460. 2007. View Article : Google Scholar : PubMed/NCBI
|
29
|
Bao S, Wu Q, McLendon RE, et al: Glioma
stem cells promote radioresistance by preferential activation of
the DNA damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
30
|
Zhang S, Balch C, Chan MW, et al:
Identification and characterization of ovarian cancer-initiating
cells from primary human tumors. Cancer Res. 68:4311–4320. 2008.
View Article : Google Scholar : PubMed/NCBI
|